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Abstract. In Saccharomyces cerevisiae the vacuolar 
protein aminopeptidase I (API) is localized to the vacu- 
ole independent of the secretory pathway. The alter- 
nate targeting mechanism used by this protein has not 
been characterized.  API is synthesized as a 61-kD solu- 
ble cytosolic precursor. Upon delivery to the vacuole, 
the amino-terminal propeptide is removed by protein- 
ase B (PrB) to yield the mature 50-kD hydrolase. We 
exploited this delivery-dependent maturation event in a 
mutant screen to identify genes whose products are in- 
volved in API targeting. Using antiserum to the API 
propeptide, we isolated mutants that accumulate pre- 
cursor API. These mutants, designated cvt, fall into 
eight complementation groups, five of which define 
novel genes. These five complementation groups ex- 
hibit a specific defect in maturation of API, but do not 
have a significant effect on vacuolar protein targeting 
through the secretory pathway. Localization studies 
show that precursor API accumulates outside of the 
vacuole in all five groups, indicating that they are 
blocked in API targeting and/or translocation. Future 
analysis of these gene products will provide informa- 
tion about the subcellular components involved in this 
alternate mechanism of vacuolar protein localization. 
S 
UBCELLULAR compartmentalization is critical to eu- 
karyotic cellular physiology. Accordingly, eukary- 
otes have evolved multiple mechanisms  to deliver 
proteins to the various membrane bound subcellular com- 
partments found in these cells. Among these organelles in 
the yeast Saccharomyces cerevisiae, the vacuole is involved 
in numerous cellular processes; the  various functions of 
the vacuole rely on the specific and efficient delivery of its 
constituent resident proteins (Klionsky et al., 1990).  Until 
recently it  was  thought  that  all  proteins  reach  this  or- 
ganelle through a portion of the secretory pathway, tran- 
siting  from  the  ER  to  the  Golgi complex before being 
sorted into the vacuolar delivery pathway. An implicit as- 
sumption in  this  thought is  that  the  ER is  the  only or- 
ganelle in this system that has the capacity to translocate 
proteins across  a  lipid  bilayer. However, it has  recently 
been shown that at least two proteins are delivered to the 
vacuole by a post-translational mechanism that is indepen- 
dent  of the  secretory pathway  (Yoshihisa  and  Anraku, 
1990;  Klionsky et al.,  1992).  The details of this alternate 
cytoplasm to vacuole targeting pathway have not been elu- 
cidated. 
Studies on various organelles in yeast have revealed that 
the ability to transport proteins across an organellar mem- 
brane is the rule rather than the exception. In addition to 
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the  ER  and  vacuole,  proteins  are  transported  directly 
across  the  membranes  of the  mitochondria  and  peroxi- 
some as well as the plasma membrane (Glick and Schatz, 
1991;  Aitchison et al.,  1992; Michaelis,  1993).  The Golgi 
complex is the principal subcellutar compartment that ap- 
pears to rely exclusively on vesicular transport for the de- 
livery of its resident proteins. Among the membranes that 
are capable of direct protein import, the ER has been ex- 
tensively characterized  (reviewed in  Pryer et  al.,  1992). 
Similarly, the protein import machinery in the mitochon- 
drial inner and outer membranes has been the subject of 
substantial research (reviewed in Hannavy et al., 1993). In 
contrast, other mechanisms, and in particular the secretory 
pathway-independent routes to the vacuole, are less well 
understood. 
The vacuole is unique in that proteins are known to en- 
ter this organelle by four different mechanisms (Fig. 1). (a) 
Most resident proteins are targeted to the vacuole via the 
secretory pathway (reviewed in Klionsky et al., 1990). This 
includes the well characterized vacuolar proteins carboxy- 
peptidase Y  (CPY) 1 and proteinase A  (PrA)  (Stevens et 
al., 1982; Klionsky et al.,  1988). (b) Extracellular proteins 
destined  for degradation  enter the  vacuole through  en- 
docytosis (Riezman, 1985; Raths et al., 1993); for example, 
1. Abbreviations used in this paper: API, aminopeptidase I; CPY, carboxy- 
peptidase Y; cvt, cytoplasm to vacuole targeting; EMS, ethyl methane sul- 
fonate; PGK, phosphoglycerate kinase; PrA, proteinase A; PrB, protein- 
ase B; vps, vacuolar protein sorting; YPD, 1% yeast extract, 2% peptone, 
and 2% dextrose media. 
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(A) Newly synthesized vacuolar proteins that contain an amino- 
terminal or internal signal sequence are cotranslationally translo- 
cated into the ER and transit,  via vesicular intermediates, to the 
trans-Golgi network, where they are sorted away from secreted 
proteins. Targeting determinants within the protein are necessary 
for this sorting event and for subsequent targeting to the vacuole. 
(B) Endocytosis provides a pathway to the vacuole for extracellu- 
lar proteins that are destined to be degraded. This pathway inter- 
sects the secretory pathway (A) at the prevacuolar or endosomal 
compartment (Davis et al., 1993; Singer-Kruger et al., 1993; Vida 
et al., 1993). (C) Autophagy is responsible for the vacuolar degra- 
dation of cytosolic components. This process occurs through the 
formation of a double-membrane vesicle containing cytosoI. The 
outer  layer  of the  autophagic  vesicle  fuses  with  the  vacuolar 
membrane to release an autophagic body into the vacuolar lumen 
for subsequent degradation (Baba et al., 1994). (D) Newly syn- 
thesized API enters the vacuole posttranslationally, using a direct 
cytoplasm to vacuole targeting mechanism. 
mating  pheromones  and  their  receptors  are  internalized 
and delivered to the vacuole via an endosomal intermedi- 
ate  (Chvatchko  et  al.,  1986;  Singer  and  Riezman,  1990; 
Davis et al.,  1993).  (c) Under starvation conditions, cyto- 
plasmic proteins are taken into the vacuole by autophago- 
cytosis (Takeshige et al., 1992; Baba et al., 1994; Thumm et 
al., 1994), presumably to allow recycling of critical metab- 
olites. (d) Some resident proteins, in particular ct-mannosi- 
dase and API, enter this organelle by an alternate  mecha- 
nism directly from the cytoplasm. It is not known if these 
two  proteins  employ  the  same  targeting  mechanism  for 
vacuolar localization. 
API serves as a useful marker protein to examine this al- 
ternate vacuolar targeting pathway (Klionsky et al., 1992). 
It is synthesized as a  soluble  cytosolic protein  containing 
an amino-terminal propeptide. Upon delivery to the vacu- 
ole, this propeptide is proteolytically removed to generate 
the  lower  molecular  mass,  mature  form  of the  enzyme. 
The signal used by AP! that allows it to be directed to the 
vacuole and sorted away from other cytoplasmic proteins 
has not been characterized.  It is  also not known if there 
are  specific receptor proteins  on the vacuolar membrane 
that recognize API and direct its interaction  with the im- 
port machinery. Overproduction of API results in accumu- 
lation of the precursor form of this hydrolase, suggesting 
that one or more of the component(s) required for import 
is saturable.  Because API enters  the vacuole posttransla- 
tionally, it may also need to interact with cytosolic chaper- 
ones (Hendrick and Hartl, 1993) that maintain a transloca- 
tion  competent  conformation.  Overproduction  of  API 
would result in the titration of these or other limiting pro- 
teins,  such as a  membrane-bound receptor, and cause the 
observed precursor accumulation phenotype. 
We decided to employ a  genetic approach to elucidate 
the  alternate  targeting  pathway  used  by API. The  deliv- 
ery-dependent maturation event was used to identify yeast 
mutants  that are  defective in this  pathway.  We have iso- 
lated  a  collection of mutants  that  accumulate  the  unpro- 
cessed precursor form of API. Of these, two complemen- 
tation groups are allelic to previously identified vps class B 
mutants (Banta et al., 1988; Raymond et al., 1992a), one is 
allelic to PRB1, the gene encoding proteinase  B, and the 
remaining five show no allelism  to tested mutants.  These 
five are phenotypically distinct from vps mutants, showing 
no secretion of CPY or significant defect in its maturation. 
Characterization  of the effects of these  mutants  on vacu- 
olar protein biogenesis indicates that the five unique com- 
plementation groups are specifically defective in targeting 
API to the yeast vacuole. Analysis of these mutants will al- 
low  the  identification  of  components  involved  in  cyto- 
plasm to vacuole protein targeting. 
Materials and Methods 
Strains and Media 
The yeast strains used in this study are listed in Table I. All yeast strains 
were grown in YPD (1% yeast extract, 2% Bacto peptone, and 2% dex- 
trose)  for  Western  analysis, or  in  synthetic  minimal  medium  supple- 
mented with the appropriate amino acids (Guthrie and Fink, 1991) for ra- 
diolabeling and immunoprecipitations. Yeast were typically grown at 30°C 
and harvested at an OD600 of 0.8 to 1.2, unless otherwise noted. Lithium 
acetate yeast transformations, genetic crosses, diploid selection, tetrad dis- 
section, and analysis, and complementation testing were carried out essen- 
tially as described (Guthrie and Fink, 1991). 
Reagents 
Zymolyase  20T  was  obtained  from  ICN  Biomedicals  (Irvine,  CA). 
Expre35S35S protein  labeling mix and autoradiographic  film were  from 
Dupont-NEN Research Products (Boston, MA). Glass beads (0.45~).52 
p,m) were  from Thomas Scientific (Sweetborough, NJ),  acrylamide and 
proteinase K were from Boehringer Mannheim Biochemical Corp. (India- 
napolis, IN), 0.45  ~ BA-S nitrocellulose was from Schleicher and Schuell 
(Keene,  NH),  and  Immobilon-P  (polyvinylidene  fluoride,  PVDF)  was 
from Millipore (Marlborough, MA). Antisera to CPY and PrA were de- 
scribed previously (Klionsky et al., 1988),  as was antiserum to peptides 
within the mature region of API (Klionsky et al., 1992).  Antisera to PrB 
and phosphoglycerate kinase (PGK) were generously provided by Charles 
Moehle and Elizabeth Jones (Moehle et al., 1989),  and Jeremy Thorner 
(Baum et al., 1978),  respectively. Autofluor was from National Diagnos- 
tics, Inc. (Manville, NJ). All other chemicals were from Sigma Chemical 
Co. (St. Louis, MO). 
Plasmids 
pRN1  (centromeric APE[) and pRC1  (2tx APE1) were both previously 
described (Klionsky et al., 1992). The plasmid encoding PRB1,  FP8 (Moehle 
et al., 1987),  was supplied by Charles Moehle and Elizabeth Jones. This 
plasmid was restriction digested with BamHI and HindIII, and the ends 
were filled in with the Klenow fragment of DNA polymerase I. The result- 
ant blunt-ended fragment was ligated into the SmaI site of plasmid pSEY8 
(Emr et al., 1986) to construct plasmid pSEY8-PRBI. 
Antibody Generation 
To produce antiserum that specifically recognized the propeptide region 
of API, a peptide was synthesized (Multiple Peptide Systems, San Diego, 
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Strain  Genotype  Source 
SEY6210  MATc~ leu2-3,  112 ura3-52 his3-A200 trpl -A901 lys2-801  suc2-A9  Robinson et al.,  1988 
SEY6211  MATa leu2-3,112  ura3-52 his3-A200  trp 1-A901 ade2-101  suc2-A9  Robinson et al.,  1988 
vpsl-6, 8-35  derived  from SEY6210 of SEY6211  Robinson et al.,  1988 
SEY210I APEP4  MATa leu2-3,112  ura3-52 ade2-101  suc2-A9 pep4::LEU2  Bankaitis  et al.,  1986 
DYY101  SEY6210 Aapel::LEU2  Klionsky et al.,  1992 
SF838-10  MATs ade6 his4-519 ura3-52  leu2,3-112  pep4-3  Rothman and Stevens, 1986 
SF838-90  MATa ade6 his4 leu2 ura3 pep4  Rothman and Stevens, 1986 
SF838-9DR2L 1  MATa his4-519  ura3-52 leu2,3-112  lys2 pep4-3  Rothman and Stevens, 1986 
vps7, 36-39,41,  43-46  derived from SF838-9DR2L1, SF838-90,  or SF838-10  Rothman and Stevens, 1986 
AFM69-1A  MATer ura3 - 1 his3,11 - 15 leu2,3-112  see7-4  Franzusoff and Schekman, 1989 
ANY123  MATc~ ura3-52 his4-619 betl  Newman et al.,  1990 
BJ993  MATer trpl pep9-2  Rothman et al.,  1989 
BJI014  MATct trpl pepl3-3  E. Jones 
BJ 1027  MATer trp I pep2-4  E. Jones 
B  J4000  MATs ade6 his 1 trp I leu2 ura3 pep7  E. Jones 
BJ4786  MATs ura3-52 leu2 trial pepl-9  E. Jones 
CTY 1-1A  MATa ura3-52 Ahis3-200  lys2-801 am sec 14-1  Bankaitis  et al.,  1989 
LW153  MATa ura3-52  ade vacl  Weisman et al.,  1990 
NY424  MATs ura3-52 see21-1  Newman et al.,  1990 
NY425  MATa ura3-52  sec22-3  Newman et al.,  1990 
RSY27  MATc~ ura3-52  his4-593  sec59-1  R. Schekman 
PBY408A  MATa ura secl 1  Bohni et al.,  1983 
RDM50-94C  MATs ura 3-52 leu2,3-112  his4 sec62  Rothblatt  et al.,  1989 
RSY12  MATer ura3-52 leu2,3-112  sec53-6  R. Schekman 
SEY5018  MATs ura3-52 leu2,3-112  sec 1-1  S. Emr 
SEY5186  MATs ura3-52 leu2,3-112  suc2-A9  sec 18-1  Klionsky et al.,  1988 
THY14  SEY6211  cvtl-1  This study 
THY193  SEY6211  cvt2-1  This study 
THY 119  SEY6211  cvt3-1  This study 
THY215  SEY6211  cvt4-2  This study 
THY313  SEY6211  cvt5-1  This study 
THY 144  SEY6211  cvt6-1  This study 
THY154  SEY6211  cvt7-1  This study 
THY 195  SEY6211  cvt8-1  This study 
CA) that corresponded to amino acid  residues 18--43 based on the de- 
duced amino acid  sequence of the APE1 gene (Chang and Smith, 1989; 
Cueva et al., 1989). The peptide (NH3-CWSNENEKKEKEENAIQNNK- 
SPEVTL) was coupled to keyhole limpet hemocyanin at the amino-termi- 
nal cysteine and used to immunize two male New Zealand White rabbits 
(0.7 mg per rabbit followed by multiple injections of 0.1 mg). 
Isolation of Mutants Defective in API Maturation 
Yeast cells  (SEY6210  transformed with pRN1) were grown overnight in 
YPD, washed twice in 50 mM sodium phosphate, pH 6.5, and then resus- 
pended in this buffer at ~10 ODr00 units. Ethylmethane sulfonate (EMS) 
was added  to a final  concentration of 30 }xl/ml, and the cells were incu- 
bated on a roller drum for 1 hour at 30°C. The cells  were washed once 
with 5%  (wt/vol) sodium thiosulfate to quench the EMS, washed twice 
with water, then spread onto YPD plates and grown 5 d at 23°C. This mu- 
tagenesis resulted in an ~50% decrease in viability. 
Two related procedures were used for mutant isolation.  In the first, col- 
ony hybridizations were made from the  original  spread plates  using a 
modified technique based on Lyons and Nelson (1984). Yeast were mu- 
tagenized with EMS as described above and spread onto YPD plates at a 
density of 150-300 colonies per plate. After 5 d growth at 23°C, a nitrocel- 
lulose filter was overlaid onto the colonies and left in place 1 min. Each fil- 
ter was then removed and placed colony side up onto a fresh YPD plate, 
followed by incubation at 23°C for 3 h. Filters were then placed on What- 
man paper saturated with 67 mM potassium phosphate, pH 7.5, 20 mM 
EDTA, 20 mM DTT, and incubated 5 min at room temperature. The fil- 
ters were then transferred to Whatman paper saturated with 5 % SDS and 
incubated for 30 min at 37°C. Cell debris was washed off of the filters un- 
der running distilled  water.  Colonies accumulating precursor API were 
identified  using the API propeptide-specific antiserum as described below. 
In the second procedure, the mutagenized ceils were spread onto YPD 
plates, grown 5 d at 23°C, and individual  colonies patched onto fresh YPD 
plates and allowed to grow for another 2 d. Colonies were transferred into 
microcentrifuge  tubes  (~0.5  to  1.0  ODr00 equivalents  per  colony)  in 
batches of 15 colonies per tube, and resuspended in 100 ~1 of lysis buffer 
(50 mM sodium phosphate, 20 mM MES, pH 7.0, 1% SDS, 3 M urea, 1 
mM sodium azide,  and  2  mM  PMSF).  Acid washed glass beads were 
added to 60% of the sample volume, and the samples mixed on a vortex 
mixer for 1 min. Each sample was then heated 10 min at 65°C and 500 ~1 
fresh lysis buffer was added. The sample was cleared of cell debris by cen- 
trifugation for 5 min at 12,500 g. A 250-1xl aliquot of the resultant lysate 
was adsorbed onto a nitrocellulose membrane using a 96-well format dot- 
blot  apparatus  (GIBCO  BRL,  Gaithersburg,  MD).  The  filters  were 
probed using the API propeptide-specific antiserum as described below. 
Batches of colonies that showed strong reactivity  to the API propeptide 
antiserum were reanalyzed by dot-blot to examine individual  colonies. 
Positive  colonies identified  by either procedure were further analyzed 
by Western blot. Fresh protein extracts were prepared by glass bead lysis 
and separated on 10%  polyacrylamide-SDS gels (Laemmli, 1970). After 
electrophoresis, the proteins were transferred (60-90 min) to PVDF mem- 
brane in transfer buffer (25  mM Tris,  192  mM glycine,  20%  methanol 
(Towbin et al., 1979) at 4°C, and the blots probed with antiserum to ma- 
ture API. 
Immunodetection 
After the dot-blot procedure, nitrocellulose membranes were autoclaved 
for 10 min in distilled  water. Both nitrocellulose and PVDF membranes 
were then blocked for at least 30 min in 100 mM Tris-HCl, 0.9%  NaCl 
with 0.1%  Tween-20 (TTBS) (Towbin et al., 1979) containing 5% nonfat 
milk. 
For immunodetection, primary antiserum to PrB was used at a dilution 
ratio of 1:10,000, antisera to API and PrA at 1:15,000, antiserum to CPY at 
1:30,000, and antiserum to PGK at  1:75,000 in "I-TBS with 0.5%  nonfat 
milk,  and incubated with the blot for 1-9 h. After incubation in primary 
Harding et al. Protein Targeting to the Yeast Vacuole  593 antiserum, all blots were washed in "VI?BS three times and incubated with 
horseradish peroxidase-conjugated goat anti-rabbit secondary antiserum 
(Cappel Labs., Cochranville, PA) at a dilution of 1:30,000 for 30~5 min. 
After incubation with the secondary antiserum, the filters were washed 
three times in TTBS, and immunoreactive bands visualized using a chemi- 
luminescent substrate (Gallagher,  1994).  Primary antiserum incubations 
of longer than 2 h were carried out at 4°C. All other incubations were car- 
ried out at room temperature. Quantification of Western blots was per- 
formed using the Biolmage analysis system (Millipore  Corp.,  Bedford, 
MA). 
Labeling and Immunoprecipitation 
Procedures for preparation and labeling of yeast ceils were essentially as 
described  (Klionsky et  al.,  1992).  Double  immunoprecipitation experi- 
ments were as described, except that each protein A-sepharose pellet was 
washed only once with Tween-IP buffer (50 mM Tris-HC1, pH 7.5,  150 
mM NaCI, 0.5% Tween-20, 0.1  mM EDTA), and protein A-sepharose- 
bound proteins were eluted at 77°C for 10 min rather than boiling for 4 
min. 
To examine secretion of CPY from whole cells, yeast were labeled as 
described (Klionsky et al., 1992)  for 20 min in the presence of BSA (2.5 
mg/ml). Nonradioactive chase was initiated by the addition of 1 mM me- 
thionine, 2 mM cysteine, and 0.2% yeast extract and continued for 60 min. 
Samples were then separated into cell and medium fractions by a 10-s cen- 
trifugation at 12,500 g, and each fraction precipitated in 10% TCA. CPY 
was immunoprecipitated from the resultant extracts as stated above, and 
analyzed by SDS-PAGE.  Quantification was done with phosphorimage 
analysis using the Fuji FUJIX BAS1000 Bioimaging Analyzer (Fuji Medi- 
cal Systems, Stamford, CT). 
Microscopy 
Vacuolar acidification was examined by quinacrine accumulation and flu- 
orescence using modifications of published procedures (Guthrie and Fink, 
1991; Morano and Klionsky, 1994).  Cells were grown in YPD to an OD600 
of 0.9-1.2, and 1.0 ml was harvested and washed once with uptake buffer 
(YPD buffered to pH 7.6 with 100 mM Hepes). The cell pellet was resus- 
pended in 50 i~1 fresh uptake buffer, and quinacrine added to a final con- 
centration of 400/zM. Cells were incubated at 30°C for 7 min, held on ice 
for 5  min, then washed three times with  ice-cold wash buffer (10 mM 
Hepes, pH 7.6, 2% glucose). Cell pellets were resuspended in 100 ~1 wash 
buffer. A 5-1xl aliquot was placed on a microscope slide, mixed with 5 I-d of 
1%  low-melt agarose, and covered with a  coverslip.  Stained cells were 
photographed  using Kodak  X-125  black  and white  film within  1  h  of 
quinacrine staining, using a Nikon Labophot-2 microscope equipped with 
direct interference contrast optics for Nomarski photomicrographs. Fluo- 
rescence filter cube BV-2B (excitation k = 40(0440 nm, emission k = 480 
nm) was used for imaging of quinacrine fluorescence. 
Endocytosis was examined by accumulation of lucifer yellow as de- 
scribed (Riezman, 1985), and cellular fluorescence was imaged as detailed 
above. 
Cell Fractionation 
Cells (20 OD600 units) were harvested at OD600 of 0.8-1.2, washed once in 
10 mM Tris-SO4, pH 9.4,  10 mM DTT, and resuspended in this buffer to 
an OD600 of 2.0. The cells were incubated for 15 min at 30°C with constant 
shaking (200-250 rpm), then harvested by centrifugation and resuspended 
in 1 M sorbitol, 20 mM Pipes, pH 6.8 (spheroplasting buffer), to an OD~ 
of ~1.0. Zymolyase 20T (0.2 mg) was added and the sample mixed gently 
by inversion. Spheroplasting was carried out at 30°C for no more than 30 
min, with gentle mixing every 4-5 rain. This procedure routinely yielded 
85-95% spheroplasts in 15 min. 
Spheroplasts were harvested by centrifugation at 3,000 g for 3 rain, re- 
suspended in  spheroplasting buffer,  and transferred  to  microcentrifuge 
tubes. The spheroplasts were harvested again at 3,000 g  for 3  min, then 
gently resuspended in i  ml of lysis buffer (150 mM sorbitol, 20 mM Pipes, 
pH 6.8), and incubated on ice for 5 rain, inverting once at 2.5 min. A 400- 
Ixl aliquot was then removed (total sample) and precipitated with acetone. 
The remaining 600-p.1 aliquot was centrifuged at 12,500 g  for 3 min, and 
the supernatant fraction removed and precipitated with acetone. The pel- 
let was washed once with another 500 i~l of lysis buffer, then precipitated. 
All precipitated  samples were  dried  and resuspended in sample buffer 
(125 mM Tris-HC1, pH 6.8, 0.4% SDS, 1% glycerol, 5% 13-mercaptoetha- 
nol) (Laemmli, 1970)  at 50 IJ.l per initial OD600 unit of cells, and analyzed 
by SDS-PAGE. 
To  examine  the  protease  sensitivity  of  the  accumulated  proAPI, 
spheroplasts  were  prepared  and  osmotically  lysed  as  above.  20D600 
equivalents of lysed spheroplasts were  then subjected either to a  mock 
protease treatment or treatment with 50 iJ.g/ml proteinase K for 30 min on 
ice in the presence or absence of 0.2%  Triton X-100. Each sample was 
then precipitated,  resuspended in sample buffer, and analyzed by SDS- 
PAGE as above. 
Results 
A Genetic Screen to Analyze Cytoplasm 
to Vacuole Targeting 
To learn more about the novel localization mechanism uti- 
lized by API we decided to isolate yeast mutants that were 
defective for API targeting but that did not affect secre- 
tory pathway transport. The unique targeting mechanism 
of API, however, was problematic for mutant  selection. 
Yeast mutants in the secretory pathway have been identi- 
fied previously using selections that relied on secretion or 
sequestration of essential proteins (Bankaitis et al., 1986; 
Figure  2.  Precursor  API  is 
not  detected  in  wild-type 
cells under  steady-state con- 
ditions.  Crude  protein  ex- 
tracts  were  prepared  from 
the  following  strains: 
SEY6210  transformed  with 
pRN1  (WT),  or  with  pRC1 
(2ix), SEY2101  Apep4 (pep4) 
and  DYY101  (z1AP/).  Ap- 
proximately 0.20D600 (lanes 
1,  2,  and  4)  or  0.05  09600 
(lane  3)  equivalents  of  cells 
of each extract were  separated  by SDS-PAGE  on two  identical 
10%  gels,  transferred  to  PVDF  membrane,  and  probed  as  de- 
scribed in Materials and Methods with (A) anti-mAPI antiserum, 
or  (B)  anti-proAPI  antiserum.  The  positions  of  precursor  and 
mature API are shown. The numbers at the right indicate the mo- 
lecular mass in kD. 
Figure 3.  The cvt mutants accumulate precursor  API.  Cell  ex- 
tracts  were  prepared  as  described  in  Materials  and  Methods. 
Identical  amounts  (0.2  OD600  equivalents of cells)  were  sepa- 
rated on three 8%  SDS-PAGE  gels. Proteins were transferred to 
PVDF  membrane  and  probed  with  anti-mAPI,  anti-PrA,  and 
anti-CPY antisera as stated in Materials and Methods. The posi- 
tion  of precursor  and mature forms of API,  PrA,  and CPY  are 
given. Wild-type  (SEY6210;  WT)  and SEY2101  Apep4 (A) con- 
tain the centromeric plasmid pRN1.  Lanes 3-10 contain  the cvt 
strains listed in Table I. Numbers at the right indicate the molecu- 
lar mass in kD. 
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1987).  Because API does not transit through the secretory 
pathway, it is not possible to select for mutants that secrete 
this hydrolase. Also, the long half-time of import of API 
into the vacuole made selections based on sequestration of 
an essential cytosolic enzyme via this pathway impossible. 
For these reasons, we decided to carry out a direct screen 
for yeast mutants that accumulate the  precursor form of 
API. 
The rationale behind this approach was based on the ob- 
servation that, even though API has a half-time of process- 
ing of 30-45 min, under steady-state conditions we do not 
usually  detect  significant  amounts  of  precursor  API  in 
wild-type cells  (Fig.  2,  lane  1).  We  could  therefore  use 
proAPI accumulation as a marker for defective targeting. 
To  identify  ceils  that  accumulate  proAPI,  we  produced 
polyclonal antiserum specific to the propeptide region of 
API. The reactivity of this antiserum (henceforth referred 
to as anti-proAPI) was compared to that of an antiserum 
directed  against sequences in the mature portion of API 
(anti-mAPI) (Klionsky et al., 1992) by Western blot (Fig. 
2). In wild-type ceils harboring a centromeric plasmid en- 
coding the APE1  gene, API is seen as a single band of 50 
kD  when  probed  with  anti-mAPI.  An  identical  blot, 
probed with anti-proAPI, shows no reactivity (Fig. 2, com- 
pare lanes I  in A  and B). When equivalent samples are ex- 
amined  from  cells  in  which  the  chromosomal  copy  of 
PEP4 is disrupted, both antisera detect a single band at 61 
kD,  corresponding  to  the  precursor form of API.  Upon 
overproduction of API from a 2Ix plasmid (pRC1), much 
of the  newly synthesized precursor API protein becomes 
incompetent for maturation (Klionsky et al.,  1992;  Fig. 2 
A, lane 3). Only the accumulated precursor is specifically 
detected by anti-proAPI antisera. There is no cross-reac- 
tivity to other proteins in yeast, as can be seen in extracts 
from the APE1 disruption strain DYY101 (Fig. 2 B, lane 4). 
Isolation  of Mutants  That Specifically 
Accumulate proAPI 
The fact that wild-type cells do not accumulate significant 
amounts of precursor API under steady-state conditions, 
coupled with the specificity of the anti-proAPI antisera, al- 
lowed  us to use  an immunoblot-based screen to identify 
mutants in cytoplasm to vacuole targeting of API. To elim- 
inate  recovery of mutants in the  gene encoding API, we 
transformed the  wild-type strain  SEY6210  with pRN1,  a 
centromeric plasmid carrying the APE1  gene. The trans- 
formed wild-type strain was mutagenized using EMS, plated 
onto nonselective media, and colonies examined immuno- 
logically for accumulation of proAPI. Two methods were 
employed for preliminary immunological identification of 
mutants: colony hybridization and dot blots (see Materials 
and  Methods).  After  preliminary  identification,  extracts 
prepared  from putative mutants  were  resolved  by SDS- 
PAGE, transferred to PVDF, and probed with anti-mAPI 
antiserum to confirm the  precursor accumulation pheno- 
type. Out of 5,300 mutagenized yeast colonies, 16 indepen- 
Figure 4.  Vacuolar morphol- 
ogy and  acidification  in  cvt 
mutants.  Yeast  strains  were 
grown  in  YPD  and  loaded 
with quinacrine  as described 
in  Materials  and  Methods. 
(A)  WT  SEY6210, THY14 
(cvtl-1),  THY193  (cvt2-1), 
THY313  (cvt5-1),  THY144 
(cvt6-1),  and THY154 (cvt7- 
1). The cvt3 mutant appears 
the  same  as  the  wild-type 
strain  (data not shown).  (B) 
THY215  (vps39/cvt4-2)  and 
THY195 (  vps41/cvt8-1); cvt4-1 
has an identical phenotype to 
cvt4-2 (data not shown). Bar, 
5 ~m. 
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significant amounts of proAPI (Fig. 3). Henceforth, we re- 
fer to these mutants as cvt, for cytoplasm to vacuole target- 
ing defective mutants. The mutants were determined to be 
unlinked to the plasmid pRN1 (data not shown), and each 
mutant was back-crossed to the isogenic wild-type strain 
(SEY6211)  a minimum of three times to remove any ex- 
traneous mutations caused by EMS treatment. After three 
backcrosses, all 16 mutants segregated 2:2 for the accumu- 
lation of precursor API, indicating that they are all caused 
by single  nuclear  mutations (data not  shown).  These  16 
mutants fell into eight complementation groups with the 
following allele distribution: cvtl has six identified alleles; 
cvt2, cvt3, and cvt4 have two alleles each; and cvt5 through 
cvt8 have one allele each. The fact that four of our comple- 
mentation groups contain only one allele suggests that our 
screen did not identify all of the genes involved in API tar- 
geting  and  delivery.  A  representative  allele  from  each 
complementation group was chosen for subsequent analy- 
sis.  None of the strains show differential accumulation of 
precursor  or mature API at elevated  (37°C)  or reduced 
(23°C) temperatures (data not shown). However, it should 
be noted that all alleles of cvt4 and cvt8 exhibit reduced 
growth  rates  at  30°C  and  above when  compared to  the 
isogenic parental strain; the remaining cvt strains show no 
apparent growth defects. 
The cvt Mutants Accumulate Precursor API 
The processing of API in protein extracts from representa- 
tive alleles of each cvt complementation group is shown in 
Fig. 3. With the exception of cvtl, all the mutants accumu- 
late essentially 100% proAPI. The cvtl allele accumulates 
one or more intermediate-sized bands under normal growth 
conditions. We believe these intermediates are the result 
of PEP4-independent removal of portions of the propep- 
tide, as equivalent bands are sometimes observed in strains 
with a disruption of the PEP4 gene (data not shown). 
As maturation of API is dependent on delivery of both 
proAPI and the PrA and PrB endoproteases to the vacu- 
ole, severe defects in the secretory pathway that affect de- 
livery of these latter hydrolases would lead to accumula- 
tion of proAPI. Though such mutations could be identified 
using this screen, they would also cause detectable defects 
in the targeting and maturation of other vacuolar hydro- 
lases that  are transported  via the  secretory pathway. To 
determine if any of the cvt mutants displayed pleiotropic 
effects  on  vacuolar  protein  targeting,  we  examined  the 
maturation state of other vacuolar hydrolases, as shown in 
Fig. 3. Based on this immunoblot analysis, most of the mu- 
tants isolated (cvt2,  cvt3,  cvtS, cvt6, and cvt7) appear to be 
specifically defective in API maturation. The cvt8 mutant 
is notable in that it severely affects the maturation of the 
two  secretory pathway targeted  proteins  CPY  and  PrA, 
accumulating  proPrA  as  well  as  low  levels  of proCPY. 
Neither of these proteases is matured to a detectable level 
in cvt8.  Alleles of cvtl  and cvt4 accumulate CPY at what 
appears to be its normal mature molecular mass of 61 kD 
at steady-state. PrA found in these strains, however, mi- 
grates  at  a  slightly higher  molecular mass  (43  kD)  than 
that observed for the wild-type strain (42 kD). It has previ- 
ously been shown  that PrA maturation is in part depen- 
dent on PrB function; in strains lacking PrB, PrA accumu- 
lates in the vacuole as an active, 43-kD form (Hirsch et al., 
1992). 
Morphology and Acidification of Vacuoles 
in cvt Mutants 
A large group of mutants (vps) has been isolated that spe- 
cifically disrupt  vacuolar targeting through  the  secretory 
pathway (reviewed in Raymond et al.,  1992b;  Stack and 
Emr,  1993).  Many of the  vps  mutants  show gross  alter- 
ations in vacuolar morphology. Maturation of API is par- 
tially blocked in several vps mutants, especially those re- 
ferred  to  as  class  C  mutants,  which  lack  an  identifiable 
vacuole  structure  when  examined  by  light  microscopy 
(Klionsky  et  al.,  1992;  Raymond  et  al.,  1992a).  Recent 
studies  also  have  shown  that  mutations  in  VMA  genes, 
which encode subunits of the vacuolar-type ATPase, result 
in lack of vacuolar acidification and cause the accumula- 
tion  of precursor forms of vacuolar proteins  that transit 
through the secretory pathway (Klionsky et al., 1992; Mo- 
rano and Klionsky, 1994).  Preliminary studies have shown 
that maturation of API is also partially defective in yeast 
that lack a functional vacuolar ATPase (K. Morano and D. 
Klionsky, unpublished  data).  For morphological  charac- 
terization  of the  cvt  mutant  strains,  we  examined  both 
structure  and  acidification  of the  vacuole.  Acidification 
can be examined directly using the vital fluorescent dye 
quinacrine;  this  acidotropic molecule has been shown  to 
accumulate in acidified compartments and has been useful 
in morphological examination of the vacuole by fluores- 
cence microscopy (Roberts et al., 1991). 
The cvt mutants were grown to mid-log phase, stained 
with  quinacrine,  and  then  examined  using  fluorescence 
and  Nomarski optics.  In all strains,  vacuoles or vacuole 
fragments were seen to stain with quinacrine,  indicating 
that there is no defect in vacuolar acidification in any of 
the  cvt  mutants  (Fig.  4).  The  cvt  vacuolar  morphology, 
however,  fell  into  two  distinct  classes  (Fig.  4,  compare 
staining in A  to that seen in B). Most of the mutants, in- 
cluding cvtl, 2, 3, 5, 6, and 7, contained one large or a few 
medium-sized, round vacuoles that were essentially indis- 
tinguishable  from those observed in  wild-type cells.  The 
second  morphological class,  containing  all  the  alleles  of 
cvt4 and cvt8 (vps39 and vps41, respectively; see below), 
showed  a  pattern  of  small,  distinct  punctate  structures 
staining  in  a  diffuse  manner  with  quinacrine  (Fig.  4  B). 
These punctate structures were also detectable by Nomar- 
ski optics. No large, single vacuole was ever observed in 
the cvt4 or cvt8 cells. This punctate morphology and stain- 
ing  pattern  is  reminiscent  of  the  vps  class  B  mutants 
(Banta et al., 1988; Raymond et al., 1992a), which accumu- 
late severely fragmented vacuoles, and exhibit pleiotropic 
defects in vacuolar protein targeting. Therefore, two lines 
of evidence indicated  that cvt4 and 8  were  vps mutants: 
both caused detectable defects in the maturation of multi- 
ple  vacuolar  proteases,  and  both  have  altered  vacuolar 
morphology. 
AUelism of cvt Mutants with Other Mutants That 
Perturb the Vacuolar System 
To  avoid extensive  examination  of previously identified 
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cvt group to known mutants (Table I). We examined mu- 
tants that have been shown to affect protein targeting, pro- 
tein maturation, and maintenance of the vacuole itself, in- 
cluding  representatives  from  the  sec,  vps,  vac,  and pep 
groups. Diploids were generated and  examined for com- 
plementation of the API precursor accumulation defect by 
Western blot (data not shown). The only allelisms encoun- 
tered were  as follows: cvt4 was unable  to complement a 
strain defective in vps39, and cvt8 was unable to comple- 
ment a strain defective in vps41, both of which are class B 
vps mutants. This result is in agreement with our Western 
analysis and  morphological observations (Figs.  3  and 4). 
Henceforth, we will refer to mutants in these complemen- 
tation groups by their previously identified gene names. 
Because PRB1 encodes the  protease directly responsi- 
ble for the maturation of API, we expected to obtain mu- 
tants defective in this gene. To determine whether or not 
the cvt mutants were defective in PRB1 production and/or 
function, we examined the processing kinetics of PrB. PrB 
is synthesized as a 76-kD preproprotein, which enters the 
secretory pathway cotranslationally at the ER and is sub- 
sequently sorted to the vacuole. It undergoes several mod- 
ifications during transit, including glycosylation and both 
PrA-dependent  and  -independent  proteolytic  cleavages, 
ultimately yielding a mature protein of 31 kD in the vacu- 
ole (Mechler et al., 1988; Moehle et al., 1989). In PrA-defi- 
cient mutants,  PrB  is targeted correctly but not  matured 
beyond its Golgi-processed form (40 kD)  (Moehle et al., 
1989) (Fig. 5). Cells were grown to mid-log phase, labeled 
with  [35S]methionine  for 5  min,  and  then  subjected  to  a 
nonradioactive chase. Samples were removed at the times 
indicated and immunoprecipitated with antiserum to PrB. 
PrB maturation and expression levels were essentially in- 
distinguishable from wild-type in cvt2, 3, 5, 6, and 7 (Fig. 5 
and data not shown). PrB in cvtl-1 appears to be produced 
at  approximately wild-type  levels,  but  is  both  processed 
more slowly and is unstable in the cell at long chase points 
(Fig. 5, 90-min chase).  The proAPI accumulation defect in 
cvtl-1  could  be complemented by transformation with a 
centromeric plasmid carrying PRB1, pSEY8-PRB1, indi- 
cating that the  alleles in this complementation group are 
defective in the gene encoding proteinase B. 
Finally, we examined the cvt mutants for defects in vacu- 
ole inheritance and endocytosis. None of the unique com- 
plementation  groups  exhibit  a  defect  in  vacuole  inheri- 
tance, based on the presence of tubular inheritance struc- 
tures and vacuoles in the buds as detected by staining with 
the vital dye FM4-64 (Vida and Emr, t995; Lois Weisman, 
personal  communication).  Vacuolar  accumulation  of ex- 
tracellular lucifer yellow was monitored as an assay for en- 
docytosis  (Riezman,  1985).  None  of the  unique  cvt mu- 
tants  show  a  defect  in  endocytosis  as  judged  by  this 
technique  (data  not  shown).  Our  allele  of  vps39  (cvt4) 
shows  only low  levels of lucifer yellow staining  in  frag- 
mented vesicles, similar to that observed with quinacrine 
(Fig. 4).  Interestingly, the  allele of vps41  (cvt8)  accumu- 
lates a small number of brightly fluorescent bodies just in- 
side of the cell periphery after a 2-h incubation with lucifer 
yellow;  at  this  time  point  the  wild-type  controls  have 
brightly stained vacuoles, as do all of the other cvt mutants 
(1, 2, 3, 5, 6, and 7). Finally, mutants in endocytosis do not 
affect API maturation (data not shown). 
The cvt2, 3, 5, 6, and 7 Mutants Are PhenotypicaUy 
Distinct from vps Mutants 
As stated earlier, there are two different pathways that are 
capable of targeting resident proteins to the yeast vacuole 
(Fig.  1):  the secretory pathway and cytoplasm to vacuole 
targeting. It is possible that the cvt mutants define a path- 
way  that  partially  overlaps  with  the  secretory  pathway. 
Many of the  vps mutants were identified  on the basis of 
missorting of a vacuolar protein that transits through the 
secretory pathway. Therefore, one of the defining charac- 
teristics of the vps mutants is that a significant proportion 
of  the  accumulated  precursor  vacuolar  proteins  are  se- 
creted outside of the cells to the medium. To test the cvt 
mutants for CPY secretion, cells were labeled for 20 rain 
then subjected  to a  60-min chase. Each sample was then 
divided into cell and medium fractions and the extracts im- 
munoprecipitated with antiserum to CPY as described in 
Materials and Methods. vpsl5, a class A  mutant (Banta et 
Figure 5.  cvtl is defective  in synthesis and maintenance of the vacuolar endoprotease PrB. WT (SEY6211 transformed with pRN1), 
Apep4 (SEY2101 Apep4 transformed with pRN1), THY14 (cvtl-1),  and THY313  (cvt5-1) cells were labeled for 5 min using [35S]me- 
thionine,  followed by a nonradioactive chase for the times indicated.  Radiolabeled cell extracts were immunoprecipitated with antise- 
rum to PrB as described  in Materials  and Methods.  The designations  pp, p, and m refer to the prepro, precursor, and mature forms of 
PrB. Numbers at the right indicate the molecular mass in kD. 
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(SEY6210),  vps and cvt mutant cells were labeled for 20 min with 
[35S]methionine in the presence of 2.5 mg/ml BSA. Chase was ini- 
tiated by the addition of methionine/cysteine (1:2 mM) and 0.2% 
yeast extract and continued for 60 min. Samples were separated 
into cell (C) and medium (M) fractions by a 10-s centrifugation at 
12,500 g  and  precipitated  in  10%  TCA.  Radiolabeled  extracts 
were immunoprecipitated with antiserum to CPY as described in 
Materials and Methods. The positions of the precursor and ma- 
ture forms of CPY are as indicated. 
al.,  1988),  was  used  as  a  control  for  vps-type  secretion; 
nearly half of the CPY present is secreted from these cells 
(Fig. 6). This is in agreement with the high levels of secre- 
tion seen previously in this strain (Robinson et al.,  1988). 
As expected, the alleles of vps39 and vps41 isolated by our 
screen  also  secrete  a  significant  proportion  of this  pro- 
tease. Strains bearing alleles of cvtl, 2, 5, 6, and 7 secreted 
less than 5% of the CPY to the medium fraction, which is 
comparable  to the  secretion  levels  observed in  the wild- 
type parental strain. The mutant cvt3 secretes a detectable 
level of CPY to the medium (7%), but this is significantly 
lower than that reported for mutants recognized as defec- 
tive in secretory pathway-mediated vacuolar protein sort- 
ing (Raymond et al., 1992a). 
Kinetics of Protein Maturation in cvt Strains 
Steady-state  analysis  indicated  that  most  of the  cvt  mu- 
tants  were  not defective for maturation  of vacuolar pro- 
teins  that  transit  through  the  secretory pathway  (Fig.  3) 
and do not secrete significant amounts of CPY to the me- 
dium  (Fig.  6)  as would be  expected  in a  vps mutant.  To 
further examine the specificity of the cvt mutants, we car- 
ried out a  kinetic analysis of vacuolar protein maturation 
(Fig. 7). Whole cells were labeled 5 min with [35S]methio- 
nine  and subjected to nonradioactive  chase for the times 
indicated. Samples were then analyzed for protein modifi- 
cations by immunoprecipitation as stated in Materials and 
Methods. 
API has a  long half-time for processing (30-45 min)  in 
comparison to secretory pathway  targeted  proteins  (Kli- 
onsky et al., 1992), and was almost completely matured at 
the  90-min  chase  point  in wild-type cells  (Fig.  7).  In the 
Apep4 control, mature API was not observed (Fig. 7). This 
was also true in all the cvt mutants,  even when the chase 
was extended to six hours (Fig. 7 and data not shown). The 
cvtl  strain  accumulates variable  amounts of intermediate 
sized proteins  at  steady-state  that  react with  API antise- 
rum  (Fig.  3).  The larger of these  forms can be seen as  a 
very faint band in the 90-min chase point of cvtl-1 (Fig. 7). 
PrA and  CPY are  known to transit  through the secre- 
tory pathway en route to the vacuole, and display process- 
ing  half-times  of 6-10  min  (reviewed  in  Klionsky  et  al., 
1990; Raymond et  al.,  1992b).  Processing of PrA was es- 
sentially indistinguishable  from wild-type in all but one of 
the cvt strains; maturation of PrA in cvtl mutants was both 
slightly  slower  than  that  observed  in  wild-type,  and  the 
"mature" band migrated at 43 kD (m*) rather than 42 kD, 
as we  had  observed  in  the  steady-state  analysis  (Fig.  3). 
This is in agreement with identification of the cvtl mutant 
as defective in PrB function (Hirsch et al., 1992). 
In PrA-deficient mutants, CPY is targeted correctly but 
not matured  beyond its  Golgi-processed  form (Fig.  7, 69 
kD)  (Ammerer  et  al.,  1986).  The  cvt  mutants  showed  a 
slight increase in the half-time of processing of CPY (Fig. 
7).  However, by the 20-min chase point, most of the cvt 
mutants  (excluding  vps39 and 41) accumulate  100%  ma- 
ture CPY (Fig. 6). We do not consider this to be a signifi- 
cant increase,  as there  is no effect on PrA processing.  It 
should be noted that cvt3 accumulates a very low amount 
of p2 CPY even at very long (90 min) chase points. This is 
Figure  7.  Most  cvt  mutants 
have specific  defects in  API 
maturation.  WT  (SEY6211 
harboring  pRN1),  apep4 
(SEY2101  Apep4  harboring 
pRN1),  THY14  (cvtl-1), 
THY193  (cvt2-1), THYll9 
(cvt3-1),  THY313  (cvt5-1), 
THY144  (cvt6-1),  and 
THY154  (cvt7-1) cells  were 
labeled  for  5  min  using 
[35S]methionine, followed by 
a nonradioactive chase as for 
the times indicated. Radiola- 
beled  cell  extracts  were  im- 
munoprecipitated  with  anti- 
sera to mAPI, CPY, and PrA 
as described in Materials and 
Methods.  Positions  of  each 
precursor  and  mature  pro- 
tein  species  are  shown,  m* 
indicates  the position  of 43- 
kD mature PrA in PrB-defi- 
cient cells. 
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5,  6,  and  7  accumulate 
proAPI outside of the vacu- 
ole.  WT  (SEY6210  with 
pRN1)  and the  specified cvt 
strains  were  grown  to  an 
OD600  of  HI,  and  10-20 
OD600 units  harvested.  The 
cells  were  converted  to 
spheroplasts, subjected to os- 
motic lysis, and samples pre- 
pared as stated in Materials and Methods. Approximately 0.2 OD600 (anti-API and anti-PrA blot) or 0.02 OD600 equivalents (anti-PGK 
blot) of protein from each fraction were separated on two identical 10% SDS-PAGE gels, transferred to PVDF membrane, and probed 
as described in Materials and Methods. Positions of each protein species are shown. Numbers at the right indicate the molecular mass in 
kD. The highest molecular mass band (~63 kD) found in the total and pellet lanes of the WT sample is not APl-specific. T, total before 
osmotic lysis; P, membrane pellet from 12,500  g centrifugation; S, supernatant from 12,500 g centrifugation. 
in concurrence with its secretion of a low level of p2 CPY 
as seen in Fig. 6. 
SubceUular Localization of Precursor API Indicates the 
cvt Mutants Block API Targeting to the Vacuole 
Two types of mutants would show a significant accumula- 
tion of precursor API in our screen.  The first  are  those 
that faithfully target API to the vacuole, but are defective 
in its maturation. The cvtl complementation group is  an 
example  of  this  type  of mutation.  The  second  class  of 
mutations we  expected to  isolate  is  that  which  contains 
mutants blocked in API targeting to the vacuole or trans- 
location across the vacuolar membrane. The fundamental 
phenotypic difference between these two types of mutants 
is the subcellular location of accumulated proAPI. In the 
first type we would expect the precursor to be inside of the 
vacuole, whereas mutants of the second type would accu- 
mulate proAPI outside the vacuole. 
To distinguish between these two types of mutants, we 
devised a  differential lysis fractionation procedure to ex- 
amine  the  subcellular  localization  of  API.  Cells  were 
spheroplasted,  then  subjected  to  gentle  osmotic lysis  to 
break  the  plasma  membrane  while  leaving  the  vacuole 
membrane  intact.  A  pellet  fraction containing vacuoles, 
and a supernatant fraction, were prepared by differential 
centrifugation. The localization of API was determined by 
Western analysis.  PrA was used  as  a  marker for soluble 
vacuolar proteins, and phosphoglycerate kinase (PGK) as 
a marker for soluble cytosolic proteins. The osmotic lysis 
method  employed  typically  released  >95%  of  the  de- 
tected PGK into the supernatant in all samples examined, 
while retaining >70% of the PrA in the pelleted fraction. 
In wild-type cells,  greater than 90%  of the  accumulated 
mature API protein is found in the pellet (Fig. 8).  Some 
precursor API can be observed in this preparation and is 
in the supernatant fraction. The amount of precursor ob- 
served in wild-type cells subjected to this lysis procedure 
varies from 30-50% of the total API detected in the sam- 
ple. We believe  that the  accumulation of proAPI in this 
experiment is due to preparation of spheroplasts; if a sam- 
ple of the cells is examined by Western blot analysis be- 
fore spheroplasting, the level of proAPI in the wild-type 
strain is consistently <10% of the total API detected (see 
Fig. 2). 
In cells  with a disrupted copy of proteinase A  (Apep4), 
API accumulates as the precursor-size band (61 kD) and is 
found in the pellet fraction; this is also true for alleles of 
cvtl (data not shown). In both of these strains, precursor 
API is targeted to the vacuole faithfully, but the vacuole 
lacks the functional protease necessary to convert API to 
the mature form. In fractionation experiments performed 
on the remaining cvt mutants, the accumulated proAPI did 
not colocalize with the vacuolar marker PrA, but rather 
was found in the 12,500 g supernatant fraction as was the 
cytosolic marker  PGK  (Fig.  8).  When  the  supernatant 
fraction was subjected to a 100,000 g spin to sediment any 
small vesicles that might remain, proAPI was still  recov- 
ered entirely in the supernatant fraction (data not shown). 
Together, these data demonstrate that API does not reach 
the vacuole in cvt 2, 3, 5, 6, and 7, and also suggest that it is 
not trapped in a vesicular intermediate. 
To further address the location of accumulated proAPI 
in cvt mutants, we determined its accessibility to protease. 
In  this  experiment,  osmotically lysed  spheroplasts  were 
subjected either to a mock protease treatment, or to treat- 
ment with proteinase K in the presence and absence of the 
detergent Triton X-100. While mature API is resistant to 
digestion by proteinase K (see Fig. 9, WT lanes), API pre- 
cursor can  be  degraded  to  lower molecular mass  forms 
(see Fig. 9, Apep4 + Tx-lO0). In both the Apep4 strain and 
cvtl, the majority of accumulated pro-API is protease-pro- 
tected unless membrane integrity is compromised by the 
addition  of detergent  (Fig 9); the  lower molecular mass 
forms of API detected in the absence of detergent are due 
to a small amount of vacuole lysis. Protease-protected pre- 
cursor API is the result that we expect if API is  unpro- 
cessed inside the vacuole, as is the case here, or is localized 
inside a small vesicle. In cvt2, 3, 5, 6, and 7 as well as our 
vps39  and 41  alleles,  proAPI was  accessible  to protease 
even in  the absence of detergent (Fig.  9),  indicating it is 
not protected in  a  membrane-bound compartment.  It is 
still possible that the precursor was located within a vesic- 
ular compartment before osmotic lysis,  but  we  consider 
this unlikely because the vacuole itself is one of the most 
osmotically sensitive  organelles,  and  its  integrity is  pre- 
served in this assay (see Fig. 9, Apep4 and cvtl lanes). To- 
gether, these data indicate that the five unique cvt mutants 
cause a specific block in targeting of API to and/or into the 
vacuole itself. 
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not  enclosed  in  a  membrane-bound  compartment.  The  yeast 
strains specified were spheroplasted and subjected to differential 
osmotic lysis as in described in Materials and Methods. 2 OD600 
equivalents of lysed spheroplasts were subjected either to a mock 
protease treatment or to treatment with 50 txg/ml proteinase K 
for  30  min  on  ice  in  the  presence  or  absence  of 0.2%  Triton 
X-100. The positions of precursor and mature API are indicated. 
Discussion 
In this study, we have identified mutants in the cytoplasm 
to vacuole targeting pathway using API as a  model pro- 
tein.  We produced  antiserum that  specifically recognizes 
the  pro-region of API, and  used this  to  screen for yeast 
mutants that accumulate high levels of the precursor form. 
Five  identified  complementation  groups  do  not  signifi- 
cantly affect vacuolar delivery of proteins that are known 
to transit through  the  secretory pathway. These mutants 
are  specific  for  API  targeting  and  are  unique  to  this 
search. 
Several  types  of defects  could  cause  accumulation  of 
proAPI in the cell, and would therefore be detected by our 
screen. For instance, as the pro-region of API is removed 
by  the  hydrolase  PrB,  we  expected  that  defects  in  the 
PRB1  gene  would  lead  to  accumulation  of proAPI.  In- 
deed, our screen identified six mutants that are alleles of 
PRB1.  Alleles in  this  complementation group (cvtl)  dis- 
play aberrant accumulation of PrB itself, either accumulat- 
ing no PrB at steady-state as seen in cvtl-1, or low levels of 
precursor bands in strains bearing other alleles (data not 
shown). The proAPI accumulation phenotype in this com- 
plementation group, as typified by cvtl-1,  could be over- 
come by transforming the  cells with a  wild-type copy of 
the PRB1 gene (data not shown). Because PrB maturation 
is dependent on proteinase A, we expected to isolate mu- 
tants in pep4. The absence of a pep4 mutant, together with 
our allele distribution,  suggests that we have not isolated 
mutants in all of the genes involved in API targeting. 
We also expected our screen to identify mutants that se- 
verely disrupt the structure and maintenance of the vacu- 
ole itself, such as certain vps mutants.  In fact, we found 
that two of the cvt mutants isolated in this study were al- 
lelic to previously identified vps class B  mutants. Class B 
mutants accumulate fragmented membrane structures that 
still share many characteristics with wild-type vacuoles. It 
has previously been noted that class B vps mutants can be 
divided  into  two  sub-groups based  on  subtle  differences 
detectable by light and electron microscopy (Raymond et 
al.,  1992a).  Interestingly, the  two  alleles  identified  here, 
vps39 and vps41, are both in the second sub-group of class 
B  mutants. This sub-group is characterized by small vacu- 
ole fragments scattered  throughout  the  cell,  which  show 
diffuse staining either with quinacrine or by immunofluo- 
rescence with antisera to the 60-kD subunit of the  vacu- 
olar ATPase (Raymond et al.,  1992a).  It is interesting to 
note that vps class B  mutants in the first sub-group (vps5 
and 17) do not have a major effect on API sorting (Klion- 
sky et al., 1992).  It is possible that the second sub-group of 
class B  mutants is specifically involved in  the  process of 
API import,  as  the  accumulated  precursor API  in  these 
mutants is not contained within a membrane-bound com- 
partment (Fig. 9). However, the defect in protease matura- 
tion is not limited to API; CPY and PrA are accumulated 
as precursor forms and/or secreted from the cells (Fig. 5). 
We therefore propose that these  strains have pleiotropic 
defects  in  vacuolar protein  delivery and  are  not  specifi- 
cally defective in cytoplasm to vacuole targeting. 
Five of our complementation groups are specifically de- 
fective for the targeting and translocation of API. This can 
be seen in the protein maturation defect, examined both 
kinetically and at steady-state, as well as the cytoplasmic 
localization of the accumulated proAPI. The specific block 
of API maturation in cvt2, 3, 5, 6, and 7 suggests that these 
gene products have a direct role in targeting this protein to 
the  vacuole.  Work is  currently  underway  to  clone  these 
genes  by complementation of the  proAPI  accumulation 
phenotype. Identification of these gene products will help 
elucidate  the  specific mechanism that mediates the  cyto- 
plasm to vacuole targeting pathway. 
The  actual  mechanism  of  protein  translocation  em- 
ployed in the targeting of API is still open to question.  It 
has been shown that API is posttranslationally localized to 
the vacuole (Klionsky et al., 1992),  and therefore the im- 
port machinery must be competent to translocate the full 
length  polypeptide.  By analogy to  more fully elucidated 
systems, this could occur via one of three general methods: 
(a) direct membrane translocation via a small active trans- 
porting protein such as an ATPase binding cassette (ABC) 
transporter  (Higgins,  1992;  Ortiz  et  al.,  1995)  or  a  large 
complex of proteins as seen in prokaryotic secretion (Wick- 
ner et al.,  1991)  and ER translocation  (Rapoport,  1992); 
(b) by vesicle formation in the cytoplasm followed by fu- 
sion with the target organelle, as seen in autophagy; and 
(c)  by membrane invagination  leading  to  vesicle forma- 
tion, as occurs during endocytosis and possibly peroxiso- 
mal import (McNew and  Goodman, 1994).  Each type of 
transport would require a certain set of proteins to medi- 
ate the translocation event. 
Direct  membrane translocation  of API is  appealing in 
that it agrees with the  observation that precursor API is 
not detected inside a  membrane-bound compartment be- 
fore its entrance into  the vacuole in the  wild-type strain 
(Klionsky et al., 1992).  Similarly the accumulated precur- 
sor is not protected from exogenously added protease in 
the cvt mutants (Fig. 9). A direct translocation mechanism 
would require one or more integral membrane protein(s) 
in  the vacuolar membrane, as well as possible associated 
peripheral proteins. We might also expect the involvement 
of cytosolic and/or vacuolar chaperones, such as a member 
of the hsp70 class (Lindquist and Craig, 1988; Terlecky et 
al., 1992;  Wickner, 1994). These factors have been shown 
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tion-competent forms and for assisting in the import pro- 
cess (Chirico et al., 1988; Deshaies  et al., 1988). This sce- 
nario is compatible with the observation that much of the 
newly synthesized API is not sorted correctly when over- 
produced (T. Harding and D. Klionsky, unpublished data). 
Overproduction may titrate out a critical cytosolic factor, 
thereby  allowing  proAPI  to  misfold  into  translocation- 
incompetent structures. 
Autophagy, on the other hand, offers an intriguing alter- 
native to direct membrane  translocation of proAPI.  Au- 
tophagy in yeast is  known to transport proteins  and or- 
ganellar  fragments  destined  for  degradation  from  the 
cytosol into the vacuolar lumen. This process involves the 
formation of a cytosolic vesicle  (autophagosome), and its 
subsequent fusion to the vacuole membrane (Takeshige et 
al., 1992; Thumm et al., 1994). This is a very slow process, 
with a half-time on the order of several hours (Noda et al., 
1995). The transport time for API, however, is much more 
rapid,  having  a  half-time  of 30--45  min.  In  addition,  au- 
tophagy  in  yeast  is  regulated  through  nutrient  sensing 
(Takeshige et al., 1992), and increases during starvation. In 
contrast, import of API is maximal during optimal growth 
conditions (unpublished results). These considerations ar- 
gue  against  a  mechanism  wherein  API  is  a  passive  sub- 
strate for the autophagic machinery. 
The third possible mechanism involves precursor bind- 
ing to the vacuolar membrane,  followed by invagination 
similar  to  that  seen  in  receptor-mediated  endocytosis. 
Though fluid phase  endocytosis is  a  relatively  slow  pro- 
cess,  molecules  such as  the  yeast  mating factors  are  en- 
docytosed  very  rapidly  and  efficiently  upon  interaction 
with cell surface  localized receptors  (Jenness et al., 1983; 
Jenness and Spatrich, 1986; Sprague, 1991). If such a sys- 
tem occurs in API transport, the requirement for interac- 
tion with a limiting number of receptor molecules  would 
explain the observed  saturability of this pathway. Direct 
uptake  at the vacuolar membrane  would not necessarily 
require the involvement of a cytosolic chaperone, as API 
could fold to very nearly its final tertiary structure before 
its interaction with the receptor. It has recently been found 
that the  yeast  peroxisome  can  directly  import  an  oligo- 
meric protein (McNew  and Goodman, 1994). One of the 
models that was proposed to explain this requires the in- 
teraction of the oligomeric protein with a receptor on the 
surface of the target organelle, followed by an as yet unde- 
termined mode of movement of the importing protein into 
the peroxisome. It is possible that a similar mechanism oc- 
curs in API targeting. We are investigating the mechanism 
of API localization to determine which elements of these 
three  general  processes  are  utilized  in  the  cytoplasm  to 
vacuole targeting pathway. 
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